FR940414-2-00047 FR940414-2-00029 [Docket No. 94N&hyph;0112] Drug Export; PHOTOPLEX Plus TM Broad Spectrum Sunscreen Lotion; Correction AGENCY: Food and Drug Administration, HHS. ACTION: Notice; correction. SUMMARY: The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of March 29, 1994 (59 FR 14627). The document announced that Allergan Herbert, Division of Allergan, Inc., had filed an application requesting approval for the export of the human drug PHOTOPLEX Plus TM Broad Spectrum Sunscreen lotion to Canada. The document was published with an inadvertent typographical error. This document corrects that error. FOR FURTHER INFORMATION CONTACT: James E. Hamilton, Center for Drug Evaluation and Research (HFD&hyph;313), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301&hyph;594&hyph;2073. In FR Doc. 94&hyph;7246, appearing on page 14627, in the Federal Register of Tuesday, March 29, 1994, the following correction is made: On page 14627, in the third column, in the title of the document, the word ``PHOTOLEX'' is corrected to read ``PHOTOPLEX''. Dated: April 8, 1994. David B. Barr, Deputy Director, Office of Compliance, Center for Drug Evaluation Research. [FR Doc. 94&hyph;9043 Filed 4&hyph;13&hyph;94; 8:45 am] BILLING CODE 4160&hyph;01&hyph;F
